Search

Your search keyword '"Koller, Paul"' showing total 12 results
Start Over Author "Koller, Paul" Journal clinical lymphoma myeloma and leukemia
12 results on '"Koller, Paul"'

1. AML-408 Comparing Intensive Purine Analogues Regimens With Cladribine and Fludarabine: CLIA-Venetoclax vs FLAG-Ida-Venetoclax for Relapsed and Refractory Acute Myeloid Leukemia During a Fludarabine Shortage

Author

Tinajero, Jose, primary, Ngo, Dat, additional, Lee, Brian, additional, Kim, Hoim, additional, Aldoss, Ibrahim, additional, Ball, Brian, additional, Koller, Paul, additional, Arslan, Shukaib, additional, Pourhassan, Hoda, additional, Otoukesh, Salman, additional, Al Malki, Monzr, additional, Stein, Anthony, additional, Nakamura, Ryotaro, additional, Sandhu, Karamjeet, additional, and Blackmon, Amanda, additional

Published
2023
Full Text
View/download PDF

2. POSTER: CML-573 ASC2ESCALATE: A US, Phase II Open-Label, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Second-Line (2L) and First-Line (1L) Treatment of Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Author

Atallah, Ehab, primary, Mauro, Michael, additional, Sasaki, Koji, additional, Levy, Moshe, additional, Koller, Paul, additional, Yang, Daisy, additional, Laine, Dramane, additional, Sabo, John, additional, Gu, Ennan, additional, and Cortes, Jorge, additional

Published
2023
Full Text
View/download PDF

3. POSTER: AML-408 Comparing Intensive Purine Analogues Regimens With Cladribine and Fludarabine: CLIA-Venetoclax vs FLAG-Ida-Venetoclax for Relapsed and Refractory Acute Myeloid Leukemia During a Fludarabine Shortage

Author

Tinajero, Jose, primary, Ngo, Dat, additional, Lee, Brian, additional, Kim, Hoim, additional, Aldoss, Ibrahim, additional, Ball, Brian, additional, Koller, Paul, additional, Arslan, Shukaib, additional, Pourhassan, Hoda, additional, Otoukesh, Salman, additional, Al Malki, Monzr, additional, Stein, Anthony, additional, Nakamura, Ryotaro, additional, Sandhu, Karamjeet, additional, and Blackmon, Amanda, additional

Published
2023
Full Text
View/download PDF

4. CML-573 ASC2ESCALATE: A US, Phase II Open-Label, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Second-Line (2L) and First-Line (1L) Treatment of Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Author

Atallah, Ehab, primary, Mauro, Michael, additional, Sasaki, Koji, additional, Levy, Moshe, additional, Koller, Paul, additional, Yang, Daisy, additional, Laine, Dramane, additional, Sabo, John, additional, Gu, Ennan, additional, and Cortes, Jorge, additional

Published
2023
Full Text
View/download PDF

5. CML-433 ASC2ESCALATE Trial in Progress: A Phase 2 Single-Arm Dose Escalation Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated With 1 Prior Tyrosine Kinase Inhibitor (TKI)

Author

Sasaki, Koji, primary, Mauro, Michael J., additional, Levy, Moshe Y., additional, Atallah, Ehab L., additional, Koller, Paul, additional, Maegawa, Rodrigo, additional, Damon, Andrea, additional, Kumar, Julie, additional, Khan, Mahmudul, additional, and Cortes, Jorge E., additional

Published
2022
Full Text
View/download PDF

6. AML-491 Real World Practice of FLAG-Idarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience

Author

Lee, Brian, primary, Blackmon, Amanda, additional, Ngo, Dat, additional, Chen, Jason, additional, Shan, Haoyue, additional, Desai, Amrita, additional, Artz, Andy, additional, Aldoss, Ibrahim, additional, Malki, Monzr Al, additional, Salhotra, Amandeep, additional, Ball, Brian, additional, Koller, Paul, additional, Pullarkat, Vinod, additional, Nakamura, Ryotaro, additional, Stein, Anthony, additional, Marcucci, Guido, additional, and Sandhu, Karamjeet, additional

Published
2022
Full Text
View/download PDF

7. Poster: CML-433 ASC2ESCALATE Trial in Progress: A Phase 2 Single-Arm Dose Escalation Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated With 1 Prior Tyrosine Kinase Inhibitor (TKI)

Author

Sasaki, Koji, primary, Mauro, Michael J., additional, Levy, Moshe Y., additional, Atallah, Ehab L., additional, Koller, Paul, additional, Maegawa, Rodrigo, additional, Damon, Andrea, additional, Kumar, Julie, additional, Khan, Mahmudul, additional, and Cortes, Jorge E., additional

Published
2022
Full Text
View/download PDF

8. Poster: AML-491 Real World Practice of FLAG-Idarubicin-Venetoclax in Relapsed Refractory AML: A Single Center Experience

Author

Lee, Brian, primary, Blackmon, Amanda, additional, Ngo, Dat, additional, Chen, Jason, additional, Shan, Haoyue, additional, Desai, Amrita, additional, Artz, Andy, additional, Aldoss, Ibrahim, additional, Malki, Monzr Al, additional, Salhotra, Amandeep, additional, Ball, Brian, additional, Koller, Paul, additional, Pullarkat, Vinod, additional, Nakamura, Ryotaro, additional, Stein, Anthony, additional, Marcucci, Guido, additional, and Sandhu, Karamjeet, additional

Published
2022
Full Text
View/download PDF

9. Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Author

Sandhu, Karamjeet S., primary, Huynh-Tran, Quy, additional, Cooper, Elise Elise, additional, Zhang, Jianying, additional, Palmer, Joycelynne, additional, Tsai, Ni-Chun, additional, Thomas, Sandra, additional, Robbins, Marjorie, additional, Aribi, Ahmed, additional, Salhotra, Amandeep, additional, Mei, Mathew, additional, Cai, Ji-Lian, additional, Spielberger, Ricardo, additional, Koller, Paul, additional, Aldoss, Ibrahim, additional, Stein, Anthony, additional, Marcucci, Guido, additional, and Budde, L. Elizabeth, additional

Published
2021
Full Text
View/download PDF

10. ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Author

Sandhu, Karamjeet S., primary, Huynh-Tran, Quy, additional, Cooper, Elise Elise, additional, zhang, Jianying, additional, Palmer, Joycelynne, additional, Tsai, Ni-Chun, additional, Thomas, Sandra, additional, Robbins, Marjorie, additional, Aribi, Ahmed, additional, Salhotra, Amandeep, additional, Mei, Mathew, additional, Cai, Ji-Lian, additional, Spielberger, Ricardo, additional, Koller, Paul, additional, Aldoss, Ibrahim, additional, Stein, Anthony, additional, Marcucci, Guido, additional, and Budde, L. Elizabeth, additional

Published
2021
Full Text
View/download PDF

11. Hyper-CVAD Plus Ofatumumab as Frontline Therapy for Adults with CD20 Positive Acute Lymphoblastic Leukemia

Author

Yilmaz, Musa, primary, Kantarjian, Hagop, additional, Ravandi, Farhad, additional, Thomas, Deborah, additional, Khouri, Maria, additional, Garcia-Manero, Guillermo, additional, Garris, Rebecca, additional, Cortes, Jorge, additional, Short, Nicholas, additional, Sasaki, Koji, additional, Issa, Ghayas, additional, Koller, Paul, additional, Schroeder, Heather, additional, Kadia, Tapan, additional, Verstovsek, Srdan, additional, Daver, Naval, additional, Jain, Nitin, additional, Konopleva, Marina, additional, O’Brien, Susan, additional, and Jabbour, Elias, additional

Published
2019
Full Text
View/download PDF

12. Frontline Ofatumumab with Hyper-CVAD in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase II Trial

Author

Maiti, Abhishek, primary, Kantarjian, Hagop, additional, Ravandi, Farhad, additional, Thomas, Deborah, additional, Khouri, Maria, additional, Garcia-Manero, Guillermo, additional, Garris, Rebecca, additional, Cortes, Jorge, additional, Short, Nicholas, additional, Sasaki, Koji, additional, Issa, Ghayas, additional, Koller, Paul, additional, Schroeder, Heather, additional, Kadia, Tapan, additional, Verstovsek, Srdan, additional, Daver, Naval, additional, Jain, Nitin, additional, Konopleva, Marina, additional, O’Brien, Susan, additional, and Jabbour, Elias, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results